Skip to main content
SpringerLink
Log in

Proteases as Targets for Therapy

  • Book
  • © 2000

Overview

Editors:
  1. Klaus Helm

    1. Max-von-Pettenkofer Institut für medizinische Mikrobiologie, LM Universität, München, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Bruce D. Korant

    1. DuPont Pharmaceutical Co Research and Development, Wilmington, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. John C. Cheronis

    1. Drug Discovery and Development, Source Precision Medicine, Boulder, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 140)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

  1. Front Matter

    Pages I-XXVIII
    Download chapter PDF

  3. Other Viral (Non-HIV) Protease Inhibitors

    1. Front Matter

      Pages 73-73
      Download chapter PDF

    2. The Proteinases Encoded by Hepatitis C Virus as Therapeutic Targets

      • C. Steinkühler, U. Koch, R. De Francesco, A. Pessi
      Pages 75-94

    3. The Human Herpes-Virus Proteases

      • C. E. Dabrowski, X. Qiu, S. S. Abdel-Meguid
      Pages 95-115

    4. The 3C Proteinases of Picornaviruses and Other Positive-Sense, Single-Stranded RNA Viruses

      • E. M. Bergmann, M. N. G. James
      Pages 117-143

    5. Adenovirus Proteinase-Antiviral Target for Triple-Combination Therapy on a Single Enzyme: Potential Inhibitor-Binding Sites

      • W. F. Mangel, D. L. Toledo, M. T. Brown, J. Ding, R. M. Sweet, D. L. Barnard et al.
      Pages 145-158

    6. Proteinases as Virulence Factors in Bacterial Diseases and as Potential Targets for Therapeutic Intervention with Proteinase Inhibitors

      • J. Potempa, J. Travis
      Pages 159-188

    7. Parasite Proteases as Targets for Therapy

      • J. H. McKerrow, C. R. Caffrey, J. P. Salter
      Pages 189-204

  4. (Non-Viral) Proteases Involved in Diseases

    1. Front Matter

      Pages 205-205
      Download chapter PDF

    2. Host Proteinases as Targets for Therapeutic Intervention

      • J. C. Cheronis
      Pages 207-219

    3. The Role of Metalloprotease Inhibitors in Cancer and Chronic Inflammatory Diseases

      • H. S. Rasmussen, K. P. Lynch
      Pages 221-234

    4. The Tumor Necrosis Factor-α Converting Enzyme

      • J. D. Becherer, M. H. Lambert, R. C. Andrews
      Pages 235-258

    5. Serine Elastases in Inflammatory and Vascular Diseases

      • J. C. Cheronis, M. Rabinovitch
      Pages 259-275

    6. Inhibitors of Thrombin and Factor Xa

      • A. H. Schmaier
      Pages 277-299

    7. Inhibitors of Papain-Like Cysteine Peptidases in Cancer

      • R. Shridhar, B. F. Sloane, D. Keppler
      Pages 301-328
Back to top

Keywords

Editors and Affiliations

  • Max-von-Pettenkofer Institut für medizinische Mikrobiologie, LM Universität, München, Germany

    Klaus Helm

  • DuPont Pharmaceutical Co Research and Development, Wilmington, USA

    Bruce D. Korant

  • Drug Discovery and Development, Source Precision Medicine, Boulder, USA

    John C. Cheronis

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation